Hologic, Inc.

Hologic, Inc.

Hologic, Inc.

Overview
Date Founded

1985

Headquarters

250 Campus Drive, Marlborough, MA, 01752, USA

Type of Company

Public

Employees (Worldwide)

5,814

Industries

Medical Products & Equipment
Wholesale: Medical Supplies & Pharmaceuticals
IT Consulting & Services
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Hologic, Inc. (Nasdaq: HOLX) is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women throughout the world. At Hologic, we are on a mission: to help women everywhere lead longer, healthier lives. It is our reason for being and the single focus of every breakthrough we pursue, every solution we design, every investment we make. Hologic is a market leader in mammography and breast biopsy, breast magnetic resonance imaging, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia and uterine fibroids, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging, and molecular diagnostic products including human papillomavirus (HPV) testing and reagents for a variety of DNA and RNA analysis applications. We are proud of our achievements and conscious of the responsibility that our leadership position brings with it. We believe that the health issues facing women today deserve and demand the singular dedication of a passionate company. Our core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health

Contact Data
Trying to get in touch with decision makers at Hologic, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Chairman President & Chief Executive Officer

Chief Financial Officer

General Counsel

Vice President, Corporate Controller & Principal Accounting Officer

Group President, International

Regional President, Asia Pacific

Group President-Breast/Skeletal Health

President, Global Service & Breast & Skeletal Health Service

Division President, Diagnostic Solutions

Board of Directors

Chairman President & Chief Executive Officer at Hologic, Inc.

Chief Executive Officer at Alexion Pharmaceuticals, Inc.

Executive Vice President & Chief Financial Officer at Incyte Corp.

Former Chief Financial Officer, Vice President of Finance & Treasurer at Infrared Industries, Inc.

Former Senior Vice President-Strategy at Medtronic Plc

Former Vice President, Operations-Australia & New Zealand at Johnson & Johnson

Independent Healthcare Consultant at Sally W. Crawford, LLC

Operating Partner at Water Street Healthcare Partners LLC

Co-Founder at Hologic, Inc.

Paths to Hologic, Inc.
Potential Connections via
Relationship Science
You
Hologic, Inc.
Owners & Shareholders
Details Hidden

Parnassus Investments is an active, long-term manager which seeks to invest in good businesses with increasingly relevant products or services, sustainable competitive advantages, quality management teams and ethical business practices. The firm uses fundamental security analysis methods in managing client accounts and they seek to identify and invest in stocks trading at large discounts to their assessment of the company's intrinsic value. Parnassus Investments offers different equity investment strategies that vary based on market capitalization and other factors as well as a fixed income strategy.

Details Hidden

Founded in 2007, ArrowMark Partners is an SEC-registered investment adviser headquartered in Denver, CO and adviser to the Meridian Funds family. The founding partners have worked together since 1995.

Details Hidden

INTECH’s investment philosophy focuses on providing a differentiated approach to portfolio management by applying mathematics to portfolio construction and is based on the mathematical foundation of Stochastic Portfolio Theory. The firm offers institutional investors relative-risk, adaptive volatility, low volatility, absolute return and market neutral products, each of which is engineered with risk controls and optimization parameters specific to the strategy’s underlying benchmark index and level of aggressiveness. Intech’s strategies include: Enhanced, Core, Growth, Value, Adaptive Volatility, Low Volatility, Absolute-Return, and Market Neutral. Portfolios can be constructed and benchmarked to S&P, Russell, MSCI, FTSE, and their respective subset indices.

Recent Transactions
Details Hidden

Hologic, Inc. purchases Mobidiag Oy from Autobio Diagnostics Co., Ltd.

Details Hidden

Hologic, Inc., Hologic Hub Ltd. purchase SuperSonic Imagine SA

Details Hidden

Hologic, Inc. purchases bioTheranostics, Inc.

Insider Transactions
Details Hidden
Transaction Advisors
Legal Advisor

Advised onHologic, Inc. purchases Focal Therapeutics, Inc. from Okapi Venture Capital LLC, EMP Management, LLC /CA

Legal Advisor

Advised onHologic, Inc. purchases Cytyc Corporation

Legal Advisor

Advised onHologic, Inc. purchases Gen-Probe, Inc.

Legal Advisor

Advised onHologic, Inc. purchases Cytyc Corporation

Legal Advisor

Advised onHologic, Inc. purchases Cytyc Corporation

Director

Advised onHologic, Inc. purchases Cytyc Corporation

Advisors & Consultants
Legal Advisor

Partner at Gibson, Dunn & Crutcher LLP

Legal Advisor

Partner at Gibson, Dunn & Crutcher LLP

Legal Advisor

Partner at Wilmer Cutler Pickering Hale and Dorr LLP

Clients

RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The firm offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. RadNet was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.

Berli Jucker Public Co. Ltd. engages in the manufacturing, packaging, and distribution of consumer and industrial products. It operates through the following five segments: Packaging Supply Chain, Consumer Supply Chain, Healthcare & Technical Supply Chain, Modern retail supply chain and Other Business Groups. The company was founded by Albert Jucker and Henry Sigg in 1882 and is headquartered in Bangkok, Thailand.

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Chief Executive Officer at Philips Medical Systems MR, Inc.

Key Stats and Financials As of 2020
Market Capitalization
$16B
Total Enterprise Value
$19.5B
Earnings Per Share
$4.21
Revenue
$3.78B
EBITDAMargin
40.42%
EBITDA
$1.53B
Total Equity
$2.71B
Net Profit
$1.12B
Enterprise Value / Sales
5.16x
Enterprise Value EBITDAOperating
12.7x
TEVNet Income
17.46x
Debt TEV
0.16x
Total Debt
$3.15B
Three Year Compounded Annual Growth Rate Of Revenue
7.28%
Investments
Details Hidden

Combinent BioMedical Systems, Inc. developed novel drug combinations and formulations. The company was founded by William F. Crowley, Jr. and Robert S. Langer, Jr. in 2000 and was headquartered in Lexington, MA.

Investors
Details Hidden

President, Chief Executive Officer & Director at BrightStar Wisconsin Foundation, Inc.

Details Hidden

Treasurer at Wisconsin Humane Society

Details Hidden

Executive Advisor at Insly Ltd.

Suppliers
Roche Holding AG Hospitals & Patient Services | Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Elbit Systems Ltd. Industrial Machinery & Manufacturing | Haifa, Israel

Elbit Systems Ltd We develop, manufacture and integrate advanced, high-performance defense electronic and electro-optic systems for customers throughout the world. The Company focuses on designing, developing, manufacturing and integrating command, control, communication, computer, intelligence, surveillance and reconnaissance (C4ISR) network centric systems, including unmanned vehicles, for defense and homeland security applications. We also perform upgrade programs for airborne, land and naval defense platforms. Moreover, we develop and manufacture systems and aero structures for the commercial aviation market. We also provide a range of support services. Our major activities include: military aircraft and helicopter systems; helmet mounted systems; commercial aviation systems and aero structures; unmanned aircraft systems; naval systems; land vehicle systems; command, control, communications, computer and intelligence (C4I) systems; electro-optic and countermeasures systems; homeland security systems; electronic warfare (EW) and signal intelligence (SIGINT) systems; and various commercial activities. Many of these major activities have a number of common and related elements. Therefore, we often jointly conduct marketing, research and development, manufacturing, performance of programs, sales and after sales support among these areas of activities. Principal Market Environment We operate primarily in the defense and homeland security arena. The nature of military actions in recent years, including low intensity conflicts and ongoing terrorist activities, has caused a shift in the defense priorities for many of our major customers. As a result we believe there is a greater demand in the areas of C4I, as well as intelligence, surveillance and reconnaissance (ISR), including network centric information systems, intelligence gathering systems, border and perimeter security systems, unmanned aircraft systems(UAS), unmanned ground vehicles (UGVs), unmanned surface vessels (USVs), remote controlled systems, space and satellite based defense capabilities and homeland security applications. There is also a growing demand for cost effective logistic support and training services. We believe our systems, products and capabilities position us to meet evolving customer requirements in several of these areas. We tailor and adapt our technologies, integration skills, market knowledge and battle-proven systems to each customer’s individual requirements in both existing and new platforms. By upgrading existing platforms with advanced electronic and electro-optic technologies, we provide customers with cost-effective solutions, and our customers are able to improve their technological and operational capabilities within limited defense budgets. We have a growing expertise in providing “systems of systems”, which enables us to increasingly provide overall solutions to our customers’ comprehensive defense and security needs. The worldwide defense market has been characterized in recent years by significant consolidation and merger and acquisition activities. Part of our growth strategy includes our continued activity in mergers and acquisitions both in Israel and internationally. We operate as a multi-domestic organization in order to meet the needs of our customers around the world. The Company’s structure enables us to benefit from the synergy of our overall capabilities while at the same time focus on local requirements. Elbit Systems shares are traded on the Nasdaq National Market (NASDAQ) under the symbol “ESLT” and on the Tel-Aviv Stock Exchange (TASE).

9342-8530 Québec, Inc. Medical Products & Equipment | Québec, Canada

9342-8530 Québec, Inc. engages in the development and provision of molecular and genomic tests to support effective clinical decisions enabling personalized medicine in oncology. The company was founded by Yves Fradet on December 8, 1994 and is headquartered in Quebec, Canada.

Competitors
Danaher Corporation Industrial Machinery & Manufacturing - Washington, DC

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

General Electric Company Power & Utilities - Boston, MA

General Electric Co. engages in the provision of technology and financial services. It operates through the following segments: Power, Renewable Energy, Aviation, Healthcare, and Capital. The Power segment offers technologies, solutions, and services related to energy production, which includes gas and steam turbines, generators, and power generation services. The Renewable Energy segment provides wind turbine platforms, hardware and software, offshore wind turbines, solutions, products and services to hydropower industry, blades for onshore and offshore wind turbines, and high voltage equipment. The Aviation segment provides jet engines and turboprops for commercial airframes, maintenance, component repair, and overhaul services, as well as replacement parts, additive machines and materials, and engineering services. The Healthcare segment provides healthcare technologies in medical imaging, digital solutions, patient monitoring, and diagnostics, drug discovery, biopharmaceutical manufacturing technologies and performance enhancement solutions. The Capital segment leases and finances aircraft, aircraft engines and helicopters, and also provides financial and underwriting solutions. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Boston, MA.

Medtronic Plc Medical Products & Equipment - Dublin, Irl

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Diabetes Group segment offers insulin pumps, coninuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Awards & Honors
Rank #790
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hologic, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hologic, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Hologic, Inc..